Gene Page: ASPSCR1
Summary ?
GeneID | 79058 |
Symbol | ASPSCR1 |
Synonyms | ASPCR1|ASPL|ASPS|RCC17|TUG|UBXD9|UBXN9 |
Description | alveolar soft part sarcoma chromosome region, candidate 1 |
Reference | MIM:606236|HGNC:HGNC:13825|Ensembl:ENSG00000169696|HPRD:06947|Vega:OTTHUMG00000178438 |
Gene type | protein-coding |
Map location | 17q25.3 |
Pascal p-value | 0.034 |
Sherlock p-value | 0.357 |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS |
Section I. Genetics and epigenetics annotation
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
MRPL20 | 0.71 | 0.68 |
OBFC2B | 0.69 | 0.62 |
TIMM10 | 0.67 | 0.64 |
C20orf24 | 0.66 | 0.61 |
AP2S1 | 0.65 | 0.62 |
PSMB6 | 0.65 | 0.59 |
MRPS11 | 0.65 | 0.62 |
RABL4 | 0.65 | 0.58 |
MRPL27 | 0.64 | 0.58 |
ATP5O | 0.64 | 0.55 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
ANPEP | -0.41 | -0.41 |
AF347015.18 | -0.38 | -0.20 |
AC010300.1 | -0.35 | -0.37 |
CDH5 | -0.34 | -0.31 |
ROBO4 | -0.34 | -0.34 |
AF347015.26 | -0.33 | -0.18 |
ENG | -0.32 | -0.29 |
PDGFRB | -0.32 | -0.29 |
EDN1 | -0.31 | -0.18 |
AC100783.1 | -0.31 | -0.21 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
MULLIGHAN MLL SIGNATURE 1 UP | 380 | 236 | All SZGR 2.0 genes in this pathway |
MULLIGHAN MLL SIGNATURE 2 UP | 418 | 263 | All SZGR 2.0 genes in this pathway |
ELVIDGE HYPOXIA DN | 146 | 94 | All SZGR 2.0 genes in this pathway |
PEREZ TP53 TARGETS | 1174 | 695 | All SZGR 2.0 genes in this pathway |
MYLLYKANGAS AMPLIFICATION HOT SPOT 12 | 11 | 8 | All SZGR 2.0 genes in this pathway |
NIKOLSKY BREAST CANCER 17Q21 Q25 AMPLICON | 335 | 181 | All SZGR 2.0 genes in this pathway |
BONOME OVARIAN CANCER POOR SURVIVAL DN | 22 | 15 | All SZGR 2.0 genes in this pathway |
BONOME OVARIAN CANCER SURVIVAL SUBOPTIMAL DEBULKING | 510 | 309 | All SZGR 2.0 genes in this pathway |
GRESHOCK CANCER COPY NUMBER UP | 323 | 240 | All SZGR 2.0 genes in this pathway |
BOYAULT LIVER CANCER SUBCLASS G6 UP | 65 | 43 | All SZGR 2.0 genes in this pathway |
CHIANG LIVER CANCER SUBCLASS CTNNB1 UP | 176 | 110 | All SZGR 2.0 genes in this pathway |
CHIANG LIVER CANCER SUBCLASS INTERFERON DN | 52 | 30 | All SZGR 2.0 genes in this pathway |
STEIN ESRRA TARGETS | 535 | 325 | All SZGR 2.0 genes in this pathway |
CAIRO HEPATOBLASTOMA UP | 207 | 143 | All SZGR 2.0 genes in this pathway |
BRUINS UVC RESPONSE EARLY LATE | 317 | 190 | All SZGR 2.0 genes in this pathway |
KUMAR PATHOGEN LOAD BY MACROPHAGES | 275 | 155 | All SZGR 2.0 genes in this pathway |